These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38487163)

  • 1. Ultrasound combined with microbubble mediated immunotherapy for tumor microenvironment.
    Wu Y; Li J; Shu L; Tian Z; Wu S; Wu Z
    Front Pharmacol; 2024; 15():1304502. PubMed ID: 38487163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect.
    Liu S; Zhang Y; Liu Y; Wang W; Gao S; Yuan W; Sun Z; Liu L; Wang C
    Br J Cancer; 2023 Mar; 128(5):715-725. PubMed ID: 36463323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound in tumor immunotherapy: Current status and future developments.
    Ho YJ; Li JP; Fan CH; Liu HL; Yeh CK
    J Control Release; 2020 Jul; 323():12-23. PubMed ID: 32302759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy.
    Han Y; Sun J; Wei H; Hao J; Liu W; Wang X
    Front Immunol; 2022; 13():937344. PubMed ID: 35844515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound and microbubble-mediated drug delivery and immunotherapy.
    Omata D; Munakata L; Maruyama K; Suzuki R
    J Med Ultrason (2001); 2022 Apr; ():. PubMed ID: 35403931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity.
    Wu Z; Li S; Zhu X
    Front Immunol; 2021; 12():682435. PubMed ID: 34194437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
    Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
    Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-intensity focused ultrasound targeted microbubble destruction reduces tumor blood supply and sensitizes anti-PD-L1 immunotherapy.
    Wu N; Cao Y; Liu Y; Zhou Y; He H; Tang R; Wan L; Wang C; Xiong X; Zhong L; Li P
    Front Bioeng Biotechnol; 2023; 11():1173381. PubMed ID: 37139047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma.
    Cai F; Zhang J; Gao H; Shen H
    Eur J Haematol; 2024 Feb; 112(2):223-235. PubMed ID: 37706523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.
    Chen Y; Sun J; Luo Y; Liu J; Wang X; Feng R; Huang J; Du H; Li Q; Tan J; Ren G; Wang X; Li H
    J Transl Med; 2022 Dec; 20(1):615. PubMed ID: 36564797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment.
    Zheng J; Huang J; Zhang L; Wang M; Xu L; Dou X; Leng X; Fang M; Sun Y; Wang Z
    Biomater Res; 2023 Feb; 27(1):9. PubMed ID: 36759928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment.
    Zhu YH; Zheng JH; Jia QY; Duan ZH; Yao HF; Yang J; Sun YW; Jiang SH; Liu DJ; Huo YM
    Cell Oncol (Dordr); 2023 Feb; 46(1):17-48. PubMed ID: 36367669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies.
    Faraj JA; Al-Athari AJH; Mohie SED; Kadhim IK; Jawad NM; Abbas WJ; Jalil AT
    Med Oncol; 2022 Sep; 39(12):239. PubMed ID: 36175691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
    Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
    Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy.
    Chen Q; Guo X; Ma W
    Oncol Res; 2023; 32(1):49-60. PubMed ID: 38188674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.